About: Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 June 1990

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 1990 (uk) article scientifique publié en 1990 (fr) im Juni 1990 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunu de 1990 (ast) scientific article published on 01 June 1990 (en)
publication date	wds:Q68514576-0F3D2CE3-7CA6-4B9F-B572-72C1E97A3806
publication date	1990-06-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q68514576-E032E0BE-8682-4C6F-8726-F65B28573E9B
language of work or name	English
author name string	wds:Q68514576-0D59671E-739A-4CFA-B424-9B4FF0DA5DD3 wds:Q68514576-1A924EEC-1680-4DFA-A2F3-E824AEBA962C wds:Q68514576-25253C5F-39F5-4746-A2B4-08BDA4B83DCE wds:Q68514576-25DE51E7-C8CE-42BF-9B2E-C78113CB6155 wds:Q68514576-3A12351E-2BE0-47AB-85D5-4F718F3183BF wds:Q68514576-5F24F65E-67EA-4032-B0F5-CA07C04014D4 wds:Q68514576-61AE2E15-075B-4C8D-9DA0-1D748AFD119A wds:Q68514576-691A07FF-E199-4C86-81D1-28A727314776 wds:Q68514576-F39E8F49-CC7A-44AC-9F56-F439DC3104A3 wds:Q68514576-FAC2535A-B44F-4647-9338-4EEE15292B07
author name string	A M Brown B Fisher D L Wickerham N V Dimitrov N Wolmark R G Margolese D Bowman A G Glass C Redmond S Legault-Poisson
rdfs:label	Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel (en) Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel (nl)
skos:prefLabel	Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel (en) Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel (nl)
name	Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel (en) Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel (nl)
title	wds:Q68514576-2E4AFFB0-0A80-4CF1-8F19-256AE133BCC1
title	Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16 (en)
page(s)	wds:Q68514576-DCDB152A-4A68-4609-90EA-4B21426D68C7
page(s)	1005-1018
instance of	wds:Q68514576-A91F2BA8-8A20-4950-9A4D-883B40567CA0
instance of	scholarly article
main subject	wds:Q68514576-44D49B7D-31F8-4725-9C3F-FADFA4EB5AC7 wds:Q68514576-6F66C6FE-E243-4F8A-9360-E9BDC91B349A wds:Q68514576-AC9609CF-88DE-46BA-B9F8-D19886606BED
main subject	breast cancer chemotherapy wd:Q412178
PubMed ID	wds:Q68514576-3EFF7C42-ECC6-4D35-8390-B53A98387B33
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2189950
PubMed ID	2189950
published in	wds:Q68514576-68D89620-32C8-46B8-A844-ECF46346DBBB
published in	Journal of Clinical Oncology
issue	wds:Q68514576-403D1CFA-77B3-4737-A47D-69372423175E
volume	wds:Q68514576-375D9C35-65E1-48E1-99CF-B01E8184168F
issue	6
volume	8
DOI	wds:Q68514576-34332A11-1218-491F-BEAB-9BE25AE62659
DOI	http://dx.doi.org/10.1200/JCO.1990.8.6.1005
DOI	10.1200/JCO.1990.8.6.1005
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q68514576
is cites work of	Combination of siRNA-directed gene silencing with epigallocatechin-3-gallate (EGCG) reverses drug resistance in human breast cancer cells Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival. High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis Evidence-based indications for postmastectomy irradiation The possible role of stromal cell stimulation in worsening the prognosis of a subset of patients with breast cancer Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer Venous thromboembolism and cancer. Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group) trial Tamoxifen versus tamoxifen plus doxorubicin and cyclophosphamide as adjuvant therapy for node-positive postmenopausal breast cancer: results of a Japan Clinical Oncology Group Study (JCOG9401). Current and future directions in medical therapy for breast carcinoma: endocrine treatment Systemic treatment after sentinel lymph node biopsy in breast cancer: who, what, and why? Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer Locoregional failure rates in patients with involved axillary nodes after mastectomy and systemic therapy Combinational treatment of gap junctional activator and tamoxifen in breast cancer cells Sentinel node biopsy: an in depth appraisal Time-Varying Effects of Breast Cancer Adjuvant Systemic Therapy Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials. Toward optimal screening strategies for older women. Costs, benefits, and harms of breast cancer screening by age, biology, and health status. Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer Multidisciplinary care for patients with breast cancer Venous thromboembolism in urologic surgery: prophylaxis, diagnosis, and treatment Should adjuvant chemotherapy be used to treat breast cancer in elderly patients (> or = 70 years of age)? Anastrozole is cost-effective vs tamoxifen as initial adjuvant therapy in early breast cancer: Canadian perspectives on the ATAC completed-treatment analysis A phase III trial of sequential adjuvant chemotherapy for operable breast carcinoma: final analysis with 10-year follow-up Clinical efficacy and prospects for use of pegylated liposomal doxorubicin in the treatment of ovarian and breast cancers Doxorubicin-based adjuvant chemotherapy in elderly breast cancer patients: the M.D. Anderson experience, with long-term follow-up A role for antiangiogenic therapy in breast cancer Concurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: a multicenter randomized phase III trial. Adjuvant therapy of breast cancer Adjuvant therapy for patients who have node-positive breast cancer Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: are all CMFs alike? The International Breast Cancer Study Group (IBCSG). Functional maps of metastases from breast cancers: proof of the principle that multidimensional scaling can summarize disease progression Will increases in dose intensity improve outcome: con. Breast cancer in elderly women: presentation, survival, and treatment options From Halsted to prevention and beyond: advances in the management of breast cancer during the twentieth century Breast cancer in the elderly

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software